Robert Thomas, MD
Sleep Medicine · Boston, MANPI 1356314983
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 85.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $13,115 and has fallen 86.9% since, to $1,717 in 2025. Among sleep medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $847.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$30K
- Harmony Biosciences LLC$3K
- ZOLL Respicardia, Inc.$1K
- AbbVie$500
- Vertex$500
- Itamar Medical Inc$216
- plus $58 from 2 others
Across 121 payments — averaging $474.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$41K
- Harmony Biosciences LLC$10K
- Zevra Therapeutics Inc$6K
What the payments were for
- Consulting fees$19,69955%
- Speaking & faculty fees$12,05234%
- Travel & lodging$2,3187%
- Food & beverage$1,5294%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 29 | $30,357 |
| Harmony Biosciences LLC | 1 | $2,800 |
| ZOLL Respicardia, Inc. | 5 | $1,167 |
| AbbVie | 1 | $500 |
| Vertex | 1 | $500 |
| Itamar Medical Inc | 2 | $216 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$14,175
- SUNOSI$6,850
- XYREM$5,862
- remede System$1,021
- WatchPATONE$203
How this compares
$35,598 in reported general payments places this provider in the 95th percentile of 51 sleep medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 34 | $461,649 |
| Sodium Oxybate | 12 | $191,068 |
| SunosiSolriamfetol Hcl | 13 | $10,217 |
| BelsomraSuvorexant | 13 | $7,219 |
| Temazepam | 14 | $2,945 |
| Acetazolamide | 71 | $1,997 |
| Modafinil | 38 | $1,553 |
| Armodafinil | 11 | $711 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $674 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $607 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $551 |
| Gabapentin | 44 | $480 |
| Zolpidem Tartrate | 38 | $183 |
| Methylphenidate Hcl | 11 | $166 |
| Eszopiclone | 15 | $120 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Boston
- John WinkelmanBoston$104K
- Suzanne BertischBoston$47K
- Sogol JavaheriBoston$15K
- Salma Batool AnwarBoston$5K
- Daniel GottliebBoston$4K
- Bethany BartleyBoston$4K
- Stuart QuanBoston$3K
- Phoebe YuBoston$3K
- Umakanth KatwaBoston$3K
- Elizabeth BengeBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.